Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
批准号:
7940433
负责人:
Subhrangsu S Mandal
金额:
$44.49万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-10 至 2013-09-30
关键词:
Adverse effectsAnimalsAssesAwarenessBehaviorBindingBiochemicalBiochemistryBiological AssayBreastCause of DeathCellsChemicalsChromatinCommunitiesCommunity OutreachDevelopmentDiseaseEmbryonic DevelopmentEndocrine DisruptorsEndocrine disruptionEnvironmental Risk FactorEnzymesEpigenetic ProcessEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogensFamilyFoodFood HabitsGene ActivationGene ExpressionGene Expression RegulationGenesGeneticGenital systemGeographic LocationsHairHandHealthHistonesHomeobox GenesHormonalHormonesHumanIncidenceKnowledgeLaboratoriesLearningLifeMalignant NeoplasmsMalignant neoplasm of prostateMediatingPesticidesPlasticsProcessRegulationRelative (related person)ReproductionResponse ElementsRiskRunningSequence AnalysisServicesSignal TransductionSkeletal DevelopmentSocietiesSourceSyndromeTranscriptional RegulationTransferaseUnited Statesbasechromatin modificationdrinking waterfoothuman diseasein vivoinsightleukemianoveloutreachparalogous genepromoterpublic health relevancereceptor bindingresearch studysteroid hormone
中文摘要
描述(由申请人提供):癌症是美国和世界各地死亡的主要原因。大量研究表明,除遗传因素外,环境因素、饮食习惯和地理位置对癌症发病率也有显著影响。在环境因素中,内分泌干扰物(EDCs)似乎是导致包括癌症在内的几种人类疾病的主要因素。EDCs是一类化学物质,它们模仿激素并干扰正常的激素功能,对人类和动物的健康产生不利影响。EDCs的来源可能包括日常食物、饮用水、塑料、杀虫剂、合成激素等。虽然EDCs是主要的健康问题,但在其内分泌干扰活动、作用机制和健康风险方面的知识仍然有限。基于我们在雌激素信号、基因调控和表观遗传生物化学方面的专业知识,我们提出:a)评估各种已知和未知的EDCs的内分泌干扰活性;b)了解它们的作用机制;c)向社会推广以提高对EDCs的认识。为了开发分析EDC活性的方法,我们建议利用雌激素应答HOX基因的启动子,这些基因在胚胎发育中起关键作用。最近,我们发现雌激素(E2)转录调控了几种HOX基因,包括HOXC13和旁系基因(HOXA13、B13和D13)。HOXC13启动子包含多个雌激素反应元件(EREs),雌激素受体(ER: ERa和ER¿)在e2介导的基因激活过程中与这些元件结合。重要的是,我们还发现混合谱系白血病(MLL)家族的组蛋白甲基转移酶是基因激活的关键参与者,与er相互作用并与这些EREs结合以调节E2存在下HOXC13的表达。基于这些发现,我们假设HOXC13及其旁系基因受er和mll(作为共调节因子)调控。在此,我们建议研究e2介导的HOXC13及其旁系基因转录调控的表观遗传调控机制,并扩展这一知识,开发新的基于细胞的检测方法,以评估各种已知和未知EDCs的内分泌干扰活性,并了解它们的作用机制。此外,我们亦建议(透过服务学习)向社会推广,以提高市民对可持续发展中心的认识。这些研究将揭示E2介导的HOX基因的表观遗传学调控机制。此外,这些研究将为EDCs的作用提供新的见解,并为评估各种已知和未知EDCs的内分泌干扰活动提供新的分析方法。外联活动将提高当地社区对环境污染物质及其与人类健康和社会的关系的认识,这将对人类健康质量产生重大影响,并可能减少癌症和其他疾病的发病率。
英文摘要
DESCRIPTION (provided by applicant): Cancer is a major cause of death in United States and around the world. Numerous studies suggest that in addition to genetic factors, environmental factors, food habit and geographic location have significant contribution to the rate of cancer incidence. Among the environmental factors Endocrine Disrupting Chemicals (EDCs) appear to be a major contributor towards several human diseases including cancer. EDCs are family of chemicals that mimic hormones and interfere with normal hormonal functions resulting in adverse effects on human and animal health. Sources of EDCs may include daily foods, drinking water, plastics, pesticides, synthetic hormones etc. Although EDCs are major health concern, knowledge is still limited in terms of their endocrine disruption activity, mechanism of action and health risk. Based on our expertise on estrogen signaling, gene regulation and epigenetics biochemistry, we proposed to a) asses the endocrine disruption activity of various known and unknown EDCs, b) understand their mechanism of action and c) outreach to the community to increase the awareness about EDCs. In order to develop assays for the analysis of EDC activity, we propose to utilize the promoter of estrogen responsive HOX genes that are key players in embryonic development. Recently, we found that estrogen (E2) transcriptionally regulates several HOX genes including HOXC13 and paralogous genes (HOXA13, B13 and D13). HOXC13 promoter contains multiple estrogen response elements (EREs) to which estrogen receptors (ER: ERa and ER¿) bind during E2-mediated gene activation. Importantly, we also found that mixed lineage leukemia (MLL) family of histone methyl-transferases that are crucial players in gene activation, interact with ERs and bind to these EREs to regulate HOXC13 expression in presence of E2. Based on these findings, we hypothesize that HOXC13 and paralogous genes are regulated by ERs and MLLs (as coregulators). Herein, we propose to investigate the epigenetic regulatory mechanisms of E2-mediated transcriptional regulation of HOXC13 and paralogous genes and expand this knowledge to develop novel cell based assays to assess the endocrine disruption activity of various known and unknown EDCs and understand their mechanisms of action. In addition, we also propose to outreach to the community (through service learning) to increase awareness about EDCs. These studies will unfold the epigenetic regulatory mechanism of E2- mediated regulation of HOX genes. In addition, these studies will provide novel insights about the action of EDCs and also provide novel assays to assess the endocrine disruption activities of various known and unknown EDCs. The outreach activity will increase the local community awareness about EDCs and their relevance to human health and society that will have high impact on quality of human health, and may reduce the incidence of cancer and other diseases.
PUBLIC HEALTH RELEVANCE: Endocrine Disrupting Chemicals (EDCs) are family of chemicals that mimic hormones and interfere with normal hormonal functions resulting in adverse effects on reproduction, behavior and development ultimately causing severe human diseases including cancer. Herein, experiments are proposed to a) asses the endocrine disruption activity of various known and unknown EDCs, b) understand their mechanism of action and c) outreach to the community to increase the awareness about EDCs. These studies will have high impact on quality of human life, health and may reduce the incidence of cancer and other diseases in long run.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.bbcan.2015.07.001
发表时间:
2015-08
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Bhan A, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1158/0008-5472.can-16-2634
发表时间:
2017-08-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Bhan A, Soleimani M, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1039/c2ra22006g
发表时间:
2013-01-01
期刊:
RSC advances
影响因子:
3.9
作者:
[Kasiri S, Ansari KI, Hussain I, Bhan A, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1038/onc.2012.352
发表时间:
2013-07-11
期刊:
ONCOGENE
影响因子:
8
作者:
[Ansari, K. I., Kasiri, S., Mandal, S. S.]
通讯作者:
Mandal, S. S.
DOI:
10.1016/j.bbagrm.2015.02.003
发表时间:
2015-06
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子:
4.7
作者:
[Hussain, Imran, Bhan, Arunoday, Ansari, Khairul I., Deb, Paromita, Bobzean, Samara A. M., Perrotti, Linda I., Mandal, Subhrangsu S.]
通讯作者:
Mandal, Subhrangsu S.
共 13 条
IDO1 regulation of SR-BI and cholesterol homeostasis in macrophages
-
批准号:10731003
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2023
-
负责人:Subhrangsu S Mandal
-
依托单位:
Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
-
批准号:7882188
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2010
-
负责人:Subhrangsu S Mandal
-
依托单位:
海外基金